Predicting the clinical course of prostate cancer

James McKiernan1, Mitchell C Benson

  • 1Department of Urology, Columbia University College of Physicians and Surgeons, New York, New York 10032, USA.

Summary

High-throughput functional genomics can improve prostate cancer risk assessment. This technology helps identify patients at higher risk of treatment failure, aiding clinical decisions.